Vestaron raised $40m in the Novo-led round, which will support the expansion of Vestaron's range of peptide-based biopesticides.
Pharmaceutical firm Novo Holdings led a $40m series B round for US-based peptide-based biopesticide developer Vestaron yesterday.
Private equity firm Open Prairie Ventures, food and agriculture-focused venture capital fund Anterra Capital and VC firms Cultivian Sandbox Ventures and Pangaea Ventures also took part in the round.
Founded in 2005 as Venomix, Vestaron has built a platform that is used to create a class of biological peptides intended to kill pests and protect crops, while being safe for humans, wildlife, pollinators…
